ASCO 2019 | Novel agents and precision medicine in prostate cancer care

Daniel Petrylak

Daniel Petrylak, MD, of the Yale School of Medicine, New Haven, CT, discusses the integration of novel agents and precision medicine into prostate cancer care at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics